Based on a report by the U.S. Department of Health & Human Services, Gilead has a greed to donate HIV medication for up to 200,000 people for up to 11 years. Gilead’s Truvada is used to reduce the risk of HIV infection and is critical to the Trump administration’s goal to eliminate the disease by 2030.
Notable Quotes: “Securing this commitment is a major step in the Trump Administration’s efforts to use the prevention and treatment tools we have to end the HIV epidemic in America by 2030. Under President Trump’s leadership, HHS worked with Gilead to secure preventative medication for individuals who might otherwise not be able to access or afford this important treatment. The majority of Americans who are at risk and who could protect themselves with PrEP are still not receiving the medication. This agreement will help close that gap substantially and deliver on President Trump’s promise to end the HIV epidemic in America.” –
Health and Human Services Secretary Alex M. Azar II